Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

A psychedelic therapist’s perspective on the role of emotional wisdom and exploring rather than suppressing discomfort.

An international team has identified associations between modifications in the placenta and the risk of developing schizophrenia, bipolar disorder, and major depression disorder.

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

A new study highlights the placenta’s role in neuropsychiatric development, showing that DNA methylation influences gene ...

From medications to neuromodulation, lifestyle changes, and emerging therapies, understand the latest evidence and best ...

Night owls showed more depressive symptoms, higher alcohol consumption, significantly poorer sleep quality and lower mindfulness practices.

In a nutshell Nearly half (48%) of depression patients don’t respond to standard treatments, revealing a significant gap in ...

The blues and the jitters are very common among people battling chronic pain, a new evidence review says. About 40% of adults ...

Tiago Costa discusses why ultrasound neuromodulation has significant potential to transform the treatment of depression ...

This FDA clearance for the Magstim Horizon 3.0 and Inspire systems builds on the existing patient TMS clearances for adult patients, making it possible for physicians and nurse practitioners to treat ...

An international team led by UPV/EHU and Biobizkaia reveals the relationship between placental DNA methylation and certain ...